| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740530 | Journal of Infection | 2017 | 37 Pages |
Abstract
In a contemporary 16-year cohort of 40 patients with hematologic cancer and mold infections of Central Nervous System, 42-day mortality was 48%. Improved survival was related to immune response in histopathology, absence of co-infections, corticosteroid tapering and possibly surgical drainage.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Minas P. Economides, Leomar Y. Ballester, Vinodh A. Kumar, Ying Jiang, Jeffrey Tarrand, Victor Prieto, Harrys A. Torres, Dimitrios P. Kontoyiannis,